224 related articles for article (PubMed ID: 33893981)
1. The relationship between diabetes-related cognitive dysfunction and leukoaraiosis.
Yuan CL; Yi R; Dong Q; Yao LF; Liu B
Acta Neurol Belg; 2021 Oct; 121(5):1101-1110. PubMed ID: 33893981
[TBL] [Abstract][Full Text] [Related]
2. Correlation between prefrontal-striatal pathway impairment and cognitive impairment in patients with leukoaraiosis.
Wang S; Yuan J; Guo X; Teng L; Jiang H; Gu H; Hu W; Jiang T
Medicine (Baltimore); 2017 Apr; 96(17):e6703. PubMed ID: 28445276
[TBL] [Abstract][Full Text] [Related]
3. Brain imaging correlates of mild cognitive impairment and early dementia in patients with type 2 diabetes mellitus.
Groeneveld O; Reijmer Y; Heinen R; Kuijf H; Koekkoek P; Janssen J; Rutten G; Kappelle L; Biessels G;
Nutr Metab Cardiovasc Dis; 2018 Dec; 28(12):1253-1260. PubMed ID: 30355471
[TBL] [Abstract][Full Text] [Related]
4. White matter hyperintensity volume predicts persistent cognitive impairment in transient ischemic attack and minor stroke.
Sivakumar L; Riaz P; Kate M; Jeerakathil T; Beaulieu C; Buck B; Camicioli R; Butcher K
Int J Stroke; 2017 Apr; 12(3):264-272. PubMed ID: 27784823
[TBL] [Abstract][Full Text] [Related]
5. Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns.
Pålhaugen L; Sudre CH; Tecelao S; Nakling A; Almdahl IS; Kalheim LF; Cardoso MJ; Johnsen SH; Rongve A; Aarsland D; Bjørnerud A; Selnes P; Fladby T
J Cereb Blood Flow Metab; 2021 May; 41(5):1162-1174. PubMed ID: 32955960
[TBL] [Abstract][Full Text] [Related]
6. Association of regional white matter hyperintensity volumes with cognitive dysfunction and vascular risk factors in patients with amnestic mild cognitive impairment.
Hirao K; Yamashita F; Sakurai S; Tsugawa A; Haime R; Fukasawa R; Sato T; Kanetaka H; Umahara T; Sakurai H; Hanyu H; Shimizu S
Geriatr Gerontol Int; 2021 Aug; 21(8):644-650. PubMed ID: 34105230
[TBL] [Abstract][Full Text] [Related]
7. The effect of midlife cardiovascular risk factors on white matter hyperintensity volume and cognition two decades later in normal ageing women.
Aljondi R; Szoeke C; Steward C; Gorelik A; Desmond P
Brain Imaging Behav; 2020 Feb; 14(1):51-61. PubMed ID: 30259291
[TBL] [Abstract][Full Text] [Related]
8. Disconnections of Cortico-Subcortical Pathways Related to Cognitive Impairment in Patients with Leukoaraiosis: A Preliminary Diffusion Tensor Imaging Study.
Yuan JL; Wang SK; Guo XJ; Teng LL; Jiang H; Gu H; Hu WL
Eur Neurol; 2017; 78(1-2):41-47. PubMed ID: 28618415
[TBL] [Abstract][Full Text] [Related]
9. Association of serum cystatin C with white matter abnormalities in patients with amnestic mild cognitive impairment.
Hirao K; Yamashita F; Tsugawa A; Haime R; Fukasawa R; Sato T; Okita M; Shimizu S; Kanetaka H; Umahara T; Sakurai H; Hanyu H
Geriatr Gerontol Int; 2019 Oct; 19(10):1036-1040. PubMed ID: 31489777
[TBL] [Abstract][Full Text] [Related]
10. Severity of white matter hyperintensities: Lesion patterns, cognition, and microstructural changes.
Zeng W; Chen Y; Zhu Z; Gao S; Xia J; Chen X; Jia J; Zhang Z
J Cereb Blood Flow Metab; 2020 Dec; 40(12):2454-2463. PubMed ID: 31865841
[TBL] [Abstract][Full Text] [Related]
11. Is type 2 diabetes related to leukoaraiosis? an updated review.
Del Bene A; Ciolli L; Borgheresi L; Poggesi A; Inzitari D; Pantoni L
Acta Neurol Scand; 2015 Sep; 132(3):147-55. PubMed ID: 25772411
[TBL] [Abstract][Full Text] [Related]
12. Carotid Artery Stiffness Accurately Predicts White Matter Hyperintensity Volume 20 Years Later: A Secondary Analysis of the Atherosclerosis Risk in the Community Study.
de Havenon A; Wong KH; Elkhetali A; McNally JS; Majersik JJ; Rost NS
AJNR Am J Neuroradiol; 2019 Aug; 40(8):1369-1373. PubMed ID: 31248859
[TBL] [Abstract][Full Text] [Related]
13. Relationship Between Type 2 Diabetes and White Matter Hyperintensity: A Systematic Review.
Wang DQ; Wang L; Wei MM; Xia XS; Tian XL; Cui XH; Li X
Front Endocrinol (Lausanne); 2020; 11():595962. PubMed ID: 33408693
[TBL] [Abstract][Full Text] [Related]
14. Associations of cognitive reserve and psychological resilience with cognitive functioning in subjects with cerebral white matter hyperintensities.
Arola A; Laakso HM; Pitkänen J; Koikkalainen J; Lötjönen J; Korvenoja A; Erkinjuntti T; Melkas S; Jokinen H
Eur J Neurol; 2021 Aug; 28(8):2622-2630. PubMed ID: 33977580
[TBL] [Abstract][Full Text] [Related]
15. Progression of cerebral white matter hyperintensities is related to leucocyte gene expression.
Jickling GC; Ander BP; Zhan X; Stamova B; Hull H; DeCarli C; Sharp FR
Brain; 2022 Sep; 145(9):3179-3186. PubMed ID: 35325079
[TBL] [Abstract][Full Text] [Related]
16. [Neural networks in the predictive diagnosis of cognitive impairment in type 1 and type 2 diabetes mellitus].
Samoilova IG; Matveeva MV; Kudlay DA; Tonkikh OS; Tolmachev IV
Ter Arkh; 2021 Nov; 93(11):1349-1358. PubMed ID: 36286658
[TBL] [Abstract][Full Text] [Related]
17. [Brain tractography in type 1 and 2 diabetes and cognitive impairment].
Samoilova YG; Matveeva MV; Tonkikh OS; Kudlay DA; Oleinik OA; Fimushkina NY; Gerget OM; Borisova AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(10):33-37. PubMed ID: 33244955
[TBL] [Abstract][Full Text] [Related]
18. Differential Effects of Confluent and Nonconfluent White Matter Hyperintensities on Functional Connectivity in Mild Cognitive Impairment.
Kumar D; Vipin A; Wong B; Ng KP; Kandiah N
Brain Connect; 2020 Dec; 10(10):547-554. PubMed ID: 33050714
[No Abstract] [Full Text] [Related]
19. Type 2 Diabetes Mellitus and Impaired Renal Function Are Associated With Brain Alterations and Poststroke Cognitive Decline.
Ben Assayag E; Eldor R; Korczyn AD; Kliper E; Shenhar-Tsarfaty S; Tene O; Molad J; Shapira I; Berliner S; Volfson V; Shopin L; Strauss Y; Hallevi H; Bornstein NM; Auriel E
Stroke; 2017 Sep; 48(9):2368-2374. PubMed ID: 28801477
[TBL] [Abstract][Full Text] [Related]
20. The Role of Disturbed Small-World Networks in Patients with White Matter Lesions and Cognitive Impairment Revealed by Resting State Function Magnetic Resonance Images (rs-fMRI).
Wang J; Chen Y; Liang H; Niedermayer G; Chen H; Li Y; Wu M; Wang Y; Zhang Y
Med Sci Monit; 2019 Jan; 25():341-356. PubMed ID: 30634184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
